Scientists have tested a vaccine that they claim can help to fight off 90 per cent of cancers, but is the real deal or just false hope?
Have scientists finally cracked the code? Is this the new wonder drug? Or is it just the pharmaceutical companies trying to extract money from the sick and the weak? It will be hard to tell until the trial goes into mainstream testing but preliminary results from clinical trials have suggested that a new vaccine called ImMucin can help patients to fight off the cancer with their own immune system.
Usually, cancer gets past your immune system because your body does not recognise the cancer cells as a threat. Tumours are formed after the cancer has deformed a patients good cells. This spreads rapidly because there is little resistance from your immune system.
However, scientists have isolated a molecule called MUC1, which is found on the surface of cancer cells and is believed to hold to secrete to killing cancer. The scientists believe that with their new vaccine a patient’s immune system can be trained to hunt down this MUC1 molecule and destroy it and the cancerous cell.
As the MUC1 molecule is found in 90 per cent of cancers the researchers believe it can be used to fight a wide range of cases.
The new vaccine, ImMucin, has been developed by the drug company Vaxil Biotherapeutics and researchers at Tel Aviv University.
The Vaccine is still in the early stages of testing, but according to the Telegraph if further trials prove to be successful the vaccine could be available within six years.
LISTEN: You Must Be Jokin’ podcast – listen to the latest episode now!
